Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein
The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome that is characterized by the development of multiple vascular tumors and is caused by inactivation of the von Hippel-Lindau protein (pVHL). Here we show that pVHL, through its beta-domain, binds directly to hypoxia-inducible factor (HIF), thereby targeting HIF for ubiquitination in an alpha-domain-dependent manner. This is the first function to be ascribed to the pVHL beta-domain. Furthermore, we provide the first direct evidence that pVHL has a function analogous to that of an F-box protein, namely, to recruit substrates to a ubiquitination machine. These results strengthen the link between overaccumulation of HIF and development of VHL disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the presence of oxygen (typically > 5% O2), the HIF-α subunit is hydroxylated by PHDs in an iron and oxygen dependent manner, which leads to HIF-α polyubiquitination by pVHL, targeting HIF-α for proteasomal degradation (Figure 2) [8].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [8]
In the citing paper
“As described in the AdPROM section, VHL acts as the substrate receptor for the Cul2-Rbx1 E3 ligase complex, recruiting HIF1α for its ubiquitination and degradation [88].”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [88]
Citations
Cites
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 1×
“Whether hypoxia and desferroxamine utilize the same molecular mechanism(s) to stabilize HIF in vivo remains to be determine”
BackgroundSalceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
Self-citationStabilization of wild-type p53 by hypoxia-inducible factor 1α
An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., & Neckers, L. M. (1998) · Nature · doi:10.1038/32925 · Cited by 827
Regulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway
Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y., & Poellinger, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6519 · Cited by 754
Tumour suppression by the human von Hippel-Lindau gene product
Iliopoulos, O., Kibel, A., Gray, S., & Kaelin, W. G. (1995) · Nature Medicine · doi:10.1038/nm0895-822 · Cited by 703
Self-citationBinding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
Kibel, A., Iliopoulos, O., DeCaprio, J. A., & Kaelin, W. G. (1995) · Science · doi:10.1126/science.7660130 · Cited by 671 · cited 1×
“pVHL normally exists in cells as a complex with elongin B and elongin C rather than as a monome”
BackgroundSelf-citationKamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W. G., Conaway, R. C., & Conaway, J. W. (1998) · Genes & Development · doi:10.1101/gad.12.24.3872 · Cited by 595 · cited 1×
“pVHL normally exists in cells as a complex with elongin B and elongin C rather than as a monome”
BackgroundSelf-citation
Cited by
Items 301–400 of 1,005
The hypoxia factor Hif-1α controls neural crest chemotaxis and epithelial to mesenchymal transition
Barriga, E. H., Maxwell, P. H., Reyes, A. E., & Mayor, R. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201212100 · Cited by 138
Conditional HIF-1α Expression Produces a Reversible Cardiomyopathy
Bekeredjian, R., Walton, C. B., MacCannell, K. A., Ecker, J., Kruse, F., Outten, J. T., Sutcliffe, D., Gerard, R. D., Bruick, R. K., & Shohet, R. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011693 · Cited by 136
“suppressor (pVHL)[8], which ultimately leads to proteosomal degradation [5,9–15].”
BackgroundMa, Z., Xiang, X., Li, S., Xie, P., Gong, Q., Goh, B.-C., & Wang, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.011 · Cited by 133
E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis
Jung, C., Hwang, K., Yoo, J., Cho, W.-K., Kim, J., Kim, W. H., & Im, D. (2006) · Nature Medicine · doi:10.1038/nm1440 · Cited by 155
Role of ERK and calcium in the hypoxia‐induced activation of HIF‐1
Mottet, D., Michel, G., Renard, P., Ninane, N., Raes, M. J., & Michiels, C. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10176 · Cited by 139
“Ubiquitinylation occurs through a E3 ubiquitin ligase complex organized by pVHL (Kamura et al., 2000; Ohh et al., 2000; Tanimoto et al., 2000) which specifically recognizes a hydroxylated proline (Pro564) on HIF1a (Ivan et al., 2001; Jaakkola et al., 2001).”
BackgroundOxygen‐dependent regulation of hypoxia‐inducible factors by prolyl and asparaginyl hydroxylation
Lando, D., Gorman, J. J., Whitelaw, M. L., & Peet, D. J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03445.x · Cited by 137
Role of nitric oxide in the regulation of HIF-1α expression during hypoxia
Agani, F. H., Puchowicz, M., Chavez, J. C., Pichiule, P., & LaManna, J. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00381.2001 · Cited by 136
“VHL is associated with elongins B and C, cullin-2, and likely other factors that constitute part of a multiprotein complex (35, 46).”
BackgroundThe regulatory roles of p53 in cardiovascular health and disease
Men, H., Cai, H., Cheng, Q., Zhou, W., Wang, X., Huang, S., Zheng, Y., & Cai, L. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03694-6 · Cited by 137
Autophagy, Stress, and Cancer Metabolism: What Doesn't Kill You Makes You Stronger
Mathew, R., & White, E. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.011015 · Cited by 123
“…TCA metabolites, as with 2-HG, leads to inhibition of prolyl hydroxylases, stabilizing Hif-1a, and constitutive activation of the hypoxia response, leading to transcriptional up-regulation of glycolysis, as observed with von Hippel–Lindau (VHL) gene deletions (Maxwell et al. 1999; Ohh et al. 2000).”
BackgroundAlbanese, A., Daly, L. A., Mennerich, D., Kietzmann, T., & Sée, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010268 · Cited by 136
“Once hydroxylated, the HIF-α proteins are recognised by an E3-ligase complex containing the von-Hippel-Lindau protein (pVHL), which acts as the substrate recognition unit and, together with Cullin-2 (Cul-2), Elongin-1, Elongin-2 and Ring-Box 1 (RBX1), polyubiquitinates K532, K538 or K567 on HIF-1α (and K497, K503 or K…”
BackgroundHypoxia-induced alternative splicing: the 11th Hallmark of Cancer
Farina, A. R., Cappabianca, L. A., Sebastiano, M., Zelli, V., Guadagni, S., & Mackay, A. R. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01616-9 · Cited by 145
The von Hippel-Lindau gene, kidney cancer, and oxygen sensing.
Kaelin, W. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092803.69761.41 · Cited by 135
Self-citationSignificance of HIF-1-active cells in angiogenesis and radioresistance
Harada, H., Kizaka‐Kondoh, S., Li, G., Itasaka, S., Shibuya, K., Inoue, M., & Hiraoka, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210556 · Cited by 144
“The modification accelerates the interaction of HIF-1a with the von Hippel–Lindau (VHL) tumor suppressor protein, resulting in the rapid ubiquitination and subsequent degradation of HIF-1a by the 26S proteasome (Cockman et al., 2000; Kamura et al., 2000; Ohh et al., 2000; Tanimoto et al., 2000).”
BackgroundCarrot and stick: HIF-α engages c-Myc in hypoxic adaptation
Huang, E. L. (2008) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402302 · Cited by 143
HIF-1 in Cell Cycle Regulation, Apoptosis, and Tumor Progression
Goda, N., Dozier, S. J., & Johnson, R. S. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603768295212 · Cited by 140
RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex
Wilkins, A., Ping, Q., & Carpenter, C. L. (2004) · Genes & Development · doi:10.1101/gad.1177904 · Cited by 132
“Mammals have six distinct cullin proteins (Cul1, Cul2, Cul3, Cul4A, Cul4B, and Cul5), all of which bind the ring finger protein Roc1 (which in turn recruits the E2 ubiquitin-conjugating enzyme) and are modified covalently by the activator Nedd8.”
BackgroundInfluentialHypoxia. 1. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets
Miyata, T., Takizawa, S., & de Strihou, C. V. Y. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00430.2010 · Cited by 143
Stabilization of Vascular Endothelial Growth Factor mRNA by Hypoxia-Inducible Factor 1
Liu, L. X., Lu, H., Luo, Y., Date, T., Belanger, A. J., Vincent, K. A., Akita, G. Y., Goldberg, M. A., Cheng, S. H., Gregory, R. J., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6551 · Cited by 145
Godschalk, R., van Schooten, F., & Bartsch, H. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.001 · Cited by 143
Mitochondrial regulation of oxygen sensing
Bell, E. L., Emerling, B. M., & Chandel, N. S. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.06.005 · Cited by 130
The biology and mechanism of action of suppressor of cytokine signaling 3
Babon, J. J., & Nicola, N. A. (2012) · Growth Factors · doi:10.3109/08977194.2012.687375 · Cited by 142
“The SOCS box-containing proteins, such as SOCS3, interact specifically with Cullin5 (as opposed to other members of the Cullin family) whereas other proteins that contain structurally similar domains and also bind elongin B/C, such as the VHL a-domain, bind to Cullin2 (Ohh et al. 1999, 2000).”
BackgroundGao, N., Shen, L., Zhang, Z., Leonard, S. S., He, H., Zhang, X., Shi, X., & Jiang, B. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000007259.65742.16 · Cited by 136
Hypoxia inducible factor-1α is an important regulator of macrophage biology
Qiu, B., Yuan, P., Du, X., Jin, H., Du, J., & Huang, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17167 · Cited by 131
Molecular Mechanism of Hypoxia-inducible Factor 1α-p300 Interaction
Gu, J., Milligan, J., & Huang, L. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009522200 · Cited by 130
Linehan, W. M., & Zbar, B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.006 · Cited by 129
Nestin as a Marker for Proliferative Endothelium in Gliomas
Sugawara, K., Kurihara, H., Negishi, M., Saito, N., Nakazato, Y., Sasaki, T., & Takeuchi, T. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780428 · Cited by 142
“Although HIF-1 is easily inducible by hypoxia, HIF-1 is readily degraded by ubiquitination in a pVHL-dependent fashion in normal vascular stromal cells (Ohh et al, 2000).”
BackgroundCD24 Is an Effector of HIF-1–Driven Primary Tumor Growth and Metastasis
Thomas, S., Harding, M. A., Smith, S. C., Overdevest, J. B., Nitz, M. D., Frierson, H. F., Tomlins, S. A., Kristiansen, G., & Theodorescu, D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3666 · Cited by 128
“Since elemental iron is a critical factor for proline hydroxylation of HIF-1α, iron chelators such as Deferoxamine (31) are widely utilized in HIF-1 studies as surrogates of hypoxia (32).”
ROS signaling as common element in low oxygen and heat stresses
Pucciariello, C., Banti, V., & Pierdomenico Perata, A. (2012) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2012.02.016 · Cited by 128
Pfander, D., Kobayashi, T., Knight, M. C., Zelzer, E., Chan, D. A., Olsen, B. R., Giaccia, A. J., Johnson, R. S., Haase, V. H., & Schipani, E. (2004) · Development · doi:10.1242/dev.01138 · Cited by 128
“…with either the loss or inactivation of the wild-type allele, following Knudson’s two hit hypothesis (Knudson and Meadows, 1980). pVHL has been shown to form a stable multiprotein complex which contains Elongin B (TCEB2), Elongin C (TCEB1), CUL2 and RBX1 (Kibel et al., 1995; Ohh et al., 2000).”
BackgroundSTAT3 inhibits the degradation of HIF-1α by pVHL-mediated ubiquitination
Jung, J. E., Kim, H. S., Lee, C. S., Shin, Y., Kim, Y.-N., Kang, G. H., Kim, T.-Y., Juhnn, Y., Kim, S. J., Park, J., et al. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.5.479 · Cited by 142
“The binding Under normoxic conditions, HIF-1α is rapidly degraded by the ubiquitin-proteasome pathway (Ohh et al., 2000).”
BackgroundSelf-citationDynamic HIF1A Regulation During Human Placental Development1
Ietta, F., Wu, Y., Winter, J., Xu, J., Wang, J., Post, M., & Caniggia, I. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.106.051557 · Cited by 127
“includes elongin B, elongin C, and cullin 2 (CUL2) [9, 10].”
BackgroundInduction of ID2 Expression by Hypoxia-inducible Factor-1
Löfstedt, T., Jögi, A., Sigvardsson, M., Gradin, K., Poellinger, L., Påhlman, S., & Axelson, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402904200 · Cited by 127
Jiang, Y., Zhang, W., Kondo, K., Klco, J. M., Martin, T. B. S., Dufault, M. R., Madden, S. F., Kaelin, W. G., & Nacht, M. (2003) · PubMed · Cited by 139
Self-citationVHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells.
Bindra, R. S., Vasselli, J. R., Stearman, R. S., Linehan, W. M., & Klausner, R. D. (2002) · PubMed · Cited by 127
Zhu, H., & Bunn, H. F. (2001) · Science · doi:10.1126/science.1060849 · Cited by 128
von Hippel-Lindau Tumor Suppressor Protein and Hypoxia-Inducible Factor in Kidney Cancer
Maynard, M. A., & Ohh, M. (2004) · American Journal of Nephrology · doi:10.1159/000075346 · Cited by 123
Self-citationKurban, G., Hudon, V., Duplan, E., Ohh, M., & Pause, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2560 · Cited by 126
Self-citationRole of hypoxia-inducible factor-1α as a cancer therapy target
Patiar, S., & Harris, A. L. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01290 · Cited by 125
Luwor, R. B., Lü, Y., Li, X., Mendelsohn, J. M., & Fan, Z. (2005) · Oncogene · doi:10.1038/sj.onc.1208625 · Cited by 132
“Prolyl hydroxylation of HIF-1a is required for its association with the von Hippel–Lindau tumor suppressor protein, which is the recognition partner of an E3 ubiquitination ligase in targeting HIF-1a for proteasomal degradation (Stebbins et al., 1999; Ohh et al., 2000).”
BackgroundZamudio, S., Wu, Y., Ietta, F., Rolfo, A., Cross, A., Wheeler, T., Post, M., Illsley, N. P., & Caniggia, I. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061185 · Cited by 124
“VHL in turn functions as the substrate recognition component of an E3 ubiquitin protein ligase complex comprising elongin B, elongin C, and Cullin-2 (the VHL complex).(10) Neural precursor cell-expressed developmentally down-regulated 8 (NEDD8) is a ubiquitin-like molecule that binds to Cullin-2 (CUL2) in the VHL comp…”
BackgroundThe Ubiquitin Ligase Siah2 and the Hypoxia Response
Nakayama, K., Qi, J., & Ronai, Z. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0458 · Cited by 122
“The E3 ligase responsible for this ubiquitination is a Skp, Cullin, F-box (SCF)-type ubiquitin ligase complex consisting of pVHL, elongin B, C (also called the VBC complex), and Rbx1 (33, 34). pVHL is the molecule recognizing the HIF-α subunit (35).”
BackgroundLee, C., Kim, S. J., Jeong, D. G., Lee, S. M., & Ryu, S. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210385200 · Cited by 121
Covello, K. L., Simon, M. C., & Keith, B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3246 · Cited by 121
Influence of the RNA-Binding Protein HuR in pVHL-Regulated p53 Expression in Renal Carcinoma Cells
Galbán, S., Martindale, J. L., Mazan-Mamczarz, K., López de Silanes, I., Fan, J., Wang, W., Decker, J., & Gorospe, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7083-7095.2003 · Cited by 117
Oxygen sensing and oxidant/redox-related pathways
Haddad, J. J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.162 · Cited by 137
The role of hypoxia-inducible factor-2 in digestive system cancers
Zhao, J., Du, F., Shen, G., Zheng, F., & Xu, B. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.565 · Cited by 122
“that directs HIF-2α polyubiquitylation and proteasomal degradation.(8) With the inhibition of PHD activity and elimina-”
BackgroundVon Hippel–Lindau: How a rare disease illuminates cancer biology
Richard, S., Gardie, B., Couvé, S., & Gad, S. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.05.005 · Cited by 131
The ubiquitin codes in cellular stress responses
Sheng, X., Xia, Z., Yang, H., & Hu, R. (2023) · Protein & Cell · doi:10.1093/procel/pwad045 · Cited by 129
“Subsequently, the VHL complex ubiquitinates several specific lysine residues on HIF-α (K532/K538/K547 on HIF-1 α , K497/503/K512 on HIF-2 α ) and triggers HIF-α proteasomal degradation (Maxwell et al. 1999; Ohh et al. 2000; Paltoglou and Roberts 2007).”
BackgroundLi, Z., Wang, D., Na, X., Schoen, S. R., Messing, E. M., & Wu, G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00534-x · Cited by 128
Mahalingam, D., Medina, E. C., Esquivel, J., Espitia, C. M., Smith, S. A., Oberheu, K., Swords, R. T., Kelly, K. R., Mita, M. M., Mita, A. C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1385 · Cited by 122
“As a component of an E3 ubiquitin ligase, von Hippel Lindau (VHL) targets HIF-1α and HIF-2α for proteasomal degradation (9).”
BackgroundSousa Fialho, M. D. L., Abd Jamil, A. H., Stannard, G. A., & Heather, L. C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.024 · Cited by 112
The hypoxia-adenosine link during inflammation
Bowser, J. L., Lee, J. W., Yuan, X., & Eltzschig, H. K. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00101.2017 · Cited by 112
Hu, M., Zhou, W., Wang, Y., Yao, D., Ye, T., Yao, Y., Chen, B., Liu, G., Yang, X., Wang, W., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.010 · Cited by 122
HIFs, Hypoxia, and Vascular Development
Covello, K. L., & Simon, M. C. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)62002-3 · Cited by 127
Hypoxia-induced angiogenesis in human hepatocellular carcinoma
Kim, K.-R., Moon, H.-E., & Kim, K. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0380-0 · Cited by 122
Benefits of hypoxic culture on bone marrow multipotent stromal cells.
Tsai, C., Yew, T., Yang, D.-C., Huang, W., & Hung, S. (2012) · PubMed · Cited by 139
Regulation of Gene Expression under Hypoxic Conditions
Nakayama, K., & Kataoka, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133278 · Cited by 123
“Under normoxic conditions in which oxygen is freely available, HIF-α is degraded by the 7 ubiquitin-proteasome pathway [12,13].”
BackgroundInfluentialHIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Hirota, K. (2021) · Biomedicines · doi:10.3390/biomedicines9050468 · Cited by 126
“HIF-1α and its family member HIF-2α are regulated in a similar manner [53,54].”
BackgroundHypoxia Stabilizes GAS6/Axl Signaling in Metastatic Prostate Cancer
Mishra, A., Wang, J., Shiozawa, Y., McGee, S., Kim, J., Jung, Y., Joseph, J., Berry, J. E., Havens, A., Pienta, K. J., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0569 · Cited by 110
“Hypoxia stabilizes Hif-1a protein by preventing its degradation (37).”
Functional Analysis of Hypoxia-inducible Factor-1α-mediated Transactivation
Ruas, J. L., Poellinger, L., & Pereira, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205051200 · Cited by 112
Rydzanicz, M., Wrzesiński, T., Bluyssen, H. A. R., & Wesoły, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.006 · Cited by 119
“pVHL hasmultiple functions,with the best documented example being its role as a substrate recognition component of an E3 ubiquitin protein ligase complex [24] and regulator of hypoxia inducible factor (HIF)a subunits (HIF1a and HIF2a) [25].”
BackgroundZhao, Q., Shen, X., Zhang, W., Zhu, G., Jin, Q., & Deng, L. (2011) · Bone · doi:10.1016/j.bone.2011.12.003 · Cited by 120
“of HIFα in the cytoplasm [13,16,17] and represents amechanism to activate HIFα signaling.”
BackgroundHypoxia inducible factor-1α: Its role in colorectal carcinogenesis and metastasis
Nagaraju, G. P., Bramhachari, P. V., Raghu, G., & El‐Rayes, B. F. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.005 · Cited by 128
Mammalian Target of Rapamycin Inhibition
Dutcher, J. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-050008 · Cited by 126
“With loss of VHL function commonly seen in clear cell renal cell cancer, there is accumulation of the oxygen-sensitive transcription factors HIF-1 and HIF-2 (24).”
BackgroundMa, W., Tessarollo, L., Hong, S., Baba, M., Southon, E. A., Back, T. C., Spence, S. E., Lobe, C. G., Sharma, N. D., Maher, G., et al. (2003) · PubMed · Cited by 131
Liu, X.-Q., Xiong, M.-H., Shu, X.-T., Tang, R.-Z., & Wang, J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300193f · Cited by 111
Abnormalities in Oxygen Sensing Define Early and Late Onset Preeclampsia as Distinct Pathologies
Rolfo, A., Many, A., Racano, A., Tal, R., Tagliaferro, A., Ietta, F., Wang, J., Post, M., & Caniggia, I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013288 · Cited by 112
Hereditary kidney cancer: Unique Opportunity for Disease‐based Therapy
Linehan, W. M., Pinto, P. A., Bratslavsky, G., Pfaffenroth, E. C., Merino, M. J., Vocke, C. D., Toro, J. R., Bottaro, D. P., Neckers, L., Schmidt, L. S., et al. (2009) · Cancer · doi:10.1002/cncr.24230 · Cited by 112
Nangaku, M., Izuhara, Y., Takizawa, S., Yamashita, T., Fujii-Kuriyama, Y., Ohneda, O., Yamamoto, M., van Ypersele de Strihou, C., Hirayama, N., & Miyata, T. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.148551 · Cited by 110
Metabolomics and Metabolic Reprogramming in Kidney Cancer
Weiss, R. H. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.006 · Cited by 116
Lee, L. Y.-H., Oldham, W. M., He, H., Wang, R., Mulhern, R., Handy, D. E., & Loscalzo, J. (2021) · Circulation · doi:10.1161/circulationaha.121.053960 · Cited by 113
Tovar‐Castillo, L. E., Cancino‐Díaz, J. C., García-Vázquez, F., Cancino‐Gómez, F. G., León‐Dorantes, G., Blancas‐González, F., Jiménez-Zamudio, L. A., García-Latorre, E., & Cancino-Diaz, M. E. (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2006.02962.x · Cited by 111
Li, L., Zhang, L., Zhang, X., Yan, Q., Minamishima, Y. A., Olumi, A. F., Mao, M., Bartz, S., & Kaelin, W. G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00282-07 · Cited by 110
“As expected, HIF protein levels were suppressed by wild-type pVHL but not by pVHL(1-115) under normoxic conditions (Fig.”
BackgroundInfluentialSelf-citationVhlh Gene Deletion Induces Hif-1-Mediated Cell Death in Thymocytes
Biju, M. P., Neumann, A. K., Bensinger, S. J., Johnson, R. S., Turka, L. A., & Haase, V. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9038-9047.2004 · Cited by 110
Hickey, M. M., Lam, J. C., Bezman, N. A., Rathmell, W. K., & Simon, M. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32614 · Cited by 110
Tumorigenic Mutations in VHL Disrupt Folding In Vivo by Interfering with Chaperonin Binding
Feldman, D. E., Spiess, C., Howard, D. E., & Frydman, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00423-4 · Cited by 126
Tanaka, H., Yamamoto, M., Hashimoto, N., Miyakoshi, M., Tamakawa, S., Yoshie, M., Tokusashi, Y., Yokoyama, K., Yaginuma, Y., & Ogawa, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1699 · Cited by 107
Haddad, J. J. (2002) · Respiratory Research · doi:10.1186/rr190 · Cited by 130
“Direct modulation of recombinant enzyme activity by graded hypoxia, iron chelation and cobaltous ions mirrored the characteristics of HIF induction in vivo, thereby fulfilling requirements for these HIF-prolyl hydroxylases to be oxygen sensors that regulate this transcription factor [91–94].”
HIF‐1α protein as a target for S‐nitrosation
Sumbayev, V. V., Budde, A., Zhou, J., & Brüne, B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03887-5 · Cited by 108
Chun, S. Y., Johnson, C., Washburn, J. G., Cruz-Correa, M. R., Dang, D. T., & Dang, L. H. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-293 · Cited by 109
“Under normoxia, HIF-1a and HIF-2a are ubiquitinated through an oxygen-dependent interaction with the von Hippel-Lindau protein (pVHL) and degraded by the 26S proteasome [12,13].”
BackgroundIvanova, A. V., Ivanov, S. V., Danilkovitch‐Miagkova, A., & Lerman, M. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010516200 · Cited by 113
Fan, L., Li, J., Yu, Z., Dang, X., & Wang, K. (2014) · BioMed Research International · doi:10.1155/2014/239356 · Cited by 119
Kaluz, S., Kaluzová, M., & Stanbridge, E. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00552-06 · Cited by 108
Rechsteiner, M. P., von Teichman, A., Nowicka, A., Sulser, T., Schraml, P., & Moch, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0757 · Cited by 103
Logsdon, D. P., Grimard, M., Luo, M., Shahda, S., Jiang, Y., Tong, Y., Yu, Z., Zyromski, N. J., Schipani, E., Carta, F., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0253 · Cited by 119
Self-citationRole for casein kinase 2 in the regulation of HIF‐1 activity
Mottet, D., Ruys, S. P. D., Demazy, C., Raes, M., & Michiels, C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21268 · Cited by 99
HIF‐1 and AP‐1 Cooperate to Increase Gene Expression in Hypoxia: Role of MAP Kinases
Michiels, C., Minet, E., Michel, G., Mottet, D., Piret, J., & Raes, M. (2001) · IUBMB Life · doi:10.1080/15216540252774766 · Cited by 103
McKnight, S. L. (2010) · Science · doi:10.1126/science.1199908 · Cited by 110
Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis
Giles, R. H., Lolkema, M. P., Snijckers, C. M. J. T., Belderbos, M. E., van der Groep, P., Mans, D. A., van Beest, M., van Noort, M., Goldschmeding, R., van Diest, P. J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209330 · Cited by 118
Schnell, P. O., Ignacak, M. L., Bauer, A. L., Striet, J. B., Paulding, W. R., & Czyzyk‐Krzeska, M. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01696.x · Cited by 107
“…transcription factors (HIFs). pVHL functions by recruiting target proteins to the complex for ubiquitination (Cockman et al. 2000; Kamura et al. 2000; Ohh et al. 2000) in a proline hydroxylation-dependent manner (Bruick and McKnight 2001; Ivan et al. 2001; Jaakkola et al. 2001; Yu et al. 2001).”
BackgroundHypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function
Manresa, M. C., & Taylor, C. T. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.02.004 · Cited by 116
Target protein localization and its impact on PROTAC-mediated degradation
Simpson, L. M., Glennie, L., Brewer, A., Zhao, J., Crooks, J., Shpiro, N., & Sapkota, G. P. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.08.004 · Cited by 114
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma
Lam, J. S., Leppert, J. T., Figlin, R. A., & Belldegrun, A. S. (2005) · Urology · doi:10.1016/j.urology.2005.06.112 · Cited by 107
To, K. K. W., & Huang, L. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504342200 · Cited by 106
Chi, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.033 · Cited by 123
Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia
Pastore, Y., Jedlickova, K., Guan, Y., Liu, E., Fahner, J., Hasle, H., Prchal, J. F., & Prchal, J. T. (2003) · The American Journal of Human Genetics · doi:10.1086/377108 · Cited by 106
“Similarly, the VHL 598CrT mutation was shown to lead to only a mild decrease in its ability to capture HIF-1a (Ang et al. 2002b).”
BackgroundInfluentialPark, J.-H., Kim, T. Y., Jong, H.-S., Kim, T. Y., Chun, Y., Park, J., Lee, C., Jung, H. C., Kim, N. K., & Bang, Y. (2003) · PubMed · Cited by 123
Self-citationDavidowitz, E. J., Schoenfeld, A. R., & Burk, R. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.865-874.2001 · Cited by 105
Hypoxia-inducible factor in brain
Sharp, F. R., Bergeron, M., & Bernaudin, M. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-3401-0_18 · Cited by 113
Geng, X., Feng, J., Liu, S., Wang, Y., Arias, C. R., & Liu, Z. (2014) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2013.12.007 · Cited by 109
Metadata
- Authors
- Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Memorial Sloan Kettering Cancer Center (US)
- Pennsylvania State University (US)
- Corresponding author
- Kaelin, William G.
- Venue
- Nature Cell Biology
- Published
- 2000-06-09
- Volume
- 2
- Issue
- 7
- Pages
- 423-427
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2147718842
- Cited by
- 1,577
- References
- 21
- Citations by year
- 2026: 23 · 2025: 36 · 2024: 46 · 2023: 36 · 2022: 49 · 2021: 56 · 2020: 59 · 2019: 45 · 2018: 40 · 2017: 50 · 2016: 52 · 2015: 45 · 2014: 62 · 2013: 66 · 2012: 70
- FWCI
- 33.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- von Hippel-Lindau protein, hypoxia-inducible factor, ubiquitination, F-box protein, protein-protein interaction, alpha-domain, von Hippel-Lindau disease, tumor suppressor, vascular tumors, E3 ubiquitin ligase
- MeSH terms
- Elongin, Cell Extracts, Deferoxamine, DNA-Binding Proteins, HeLa Cells, Humans, Ligases, Mutation, Nuclear Proteins, Oxygen, Protein Binding, Protein Processing, Post-Translational, Proteins, Transcription Factors, Transfection, Tumor Cells, Cultured, Ubiquitins, Protein Structure, Tertiary, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.